EFFICACY AND SAFETY OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION: A 10-YEAR EXPERIENCE OF A LARGEVOLUME FMT CENTER

被引：0

作者：

Ianiro, G. ^{[1
]}

Masucci, L. ^{[2
]}

Severino, A. ^{[1
]}

Fiorani, M. ^{[1
]}

Varca, S. ^{[1
]}

Porcari, S. ^{[1
]}

Bibbo, S. ^{[1
]}

Quaranta, G. ^{[2
]}

Rondinella, D. ^{[1
]}

Pelliccia, F. ^{[1
]}

Altieri, G. ^{[1
]}

Ruggiero, S. ^{[1
]}

Fusco, W. ^{[1
]}

Rozera, T. ^{[1
]}

Ingrosso, M. R. ^{[1
]}

Fancello, G. ^{[2
]}

Sanguinetti, M. ^{[2
]}

Gasbarrini, A. ^{[1
]}

Cammarota, G. ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurgia Traslaz, Gastroenterol, Rome, Italy

[2] Univ Cattolica Sacro Cuore, Microbiol Unit, Fdn Policlin Univ Gemelli IRCCS, Rome, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

BOC.02.1

引用

页码：S108 / S109

页数：2

共 50 条

[1] Safety and efficacy of fecal microbiota transplantation (FMT) in the management of recurrent clostridioides difficile infection (rCDI) in cancer patients.
Ali, Hiba
Ma, Weijie
Khurana, Shruti
Jiang, Zhi-Dong
DuPont, Herbert L.
Okhuysen, Pablo
Thomas, Anusha
Wang, Yinghong
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[2] EFFICACY AND SAFETY OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF SEVERE AND SEVERE-COMPLICATED CLOSTRIDIOIDES DIFFICILE INFECTION: REPORT FROM A LARGE-VOLUME FMT CENTER
Ianiro, G.
Masucci, L.
Severino, A.
Varca, S.
Fiorani, M.
Porcari, S.
Bibbo, S.
Quaranta, G.
Rondinella, D.
Fusco, W.
Rozera, T.
Iannarelli, F.
Sanguinetti, M.
Gasbarrini, A.
Cammarota, G.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S105 - S105
[3] Safety and Efficacy of Fecal Microbiota Transplantation (FMT) for Recurrent Clostridium difficile Infection (RCDI) in Septuagenarians, Octogenarians, and Nonegenarians: A Single-Center Experience
Anand, Rohit
Girotra, Mohit
Garg, Shashank
Dutta, Sudhir
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S195 - S195
[4] Efficacy of Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Patients
Berry, Parul
Tariq, Raseen
Pardi, Darrell S.
Khanna, Sahil
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S220 - S221
[5] Efficacy and safety of commercialized fecal microbiota transplant for the treatment of recurrent Clostridioides difficile infection
Yendrapalli, Usha
Edwards, Jonathan
Belk, Madeline
Steuber, Taylor
Hassoun, Ali
INFECTION DISEASE & HEALTH, 2023, 28 (01) : 71 - 73
[6] The Role of Loperamide in Conjunction With Fecal Microbiota Transplantation (FMT) for Recurrent Clostridioides difficile Infection (rCDI)
Nayi, Vipul
Brandt, Lawrence
Aroniadis, Olga
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S97 - S98
[7] FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: COMMUNITY EXPERIENCE IN NAPLES FLORIDA FROM 2014 TO 2019
Jarbath, Medjine
Phillips, Raymond W.
GASTROENTEROLOGY, 2023, 164 (06) : S702 - S702
[8] Fecal microbiota transplantation through colonoscopy in the treatment of recurrent Clostridioides difficile: Experience at a university center
Quera, R.
Nunez, P.
von Muhlenbrock, C.
Espinoza, R.
REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2024, 89 (04): : 513 - 520
[9] Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection
Voth, Elida
Khanna, Sahil
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (07) : 669 - 676
[10] Fecal microbiota transplantation for recurrent Clostridioides difficile infection
Haber, Stacy L.
Raney, Carrington R. K.
Larson, Trent L.
Lau, Jennifer Park
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (13) : 935 - 942

← 1 2 3 4 5 →